Impacts of Total Glucosides of Paeonia on the Proliferation Migration and Oxaliplatin Resistance of Colorectal Cancer Cells by Regulating FAK/MEK/ERK Signaling Pathway

Expand
  • Department of Pharmacy Shuyang Affiliated Hospital Nanjing University of Chinese Medicine Jiangsu Suqian 223600, China

Received date: 2025-05-22

  Revised date: 2025-08-04

  Accepted date: 2026-02-06

  Online published: 2026-02-11

Abstract

Objective: To explore the impacts of total glucosides of paeonia on the proliferation migration and resistance to oxaliplatin L-OPP of colorectal cancer cells by regulating focal adhesion kinase FAK/mitogen activated protein kinase kinase MEK/extracellular regulated protein kinase ERK signaling pathway.Methods: Human colorectal cancer HCT116 cells were cultured in vitro and assigned into the control group low medium and high-dose total glucosides of paeonia groups 25 50 100 μg·mL-1 total glucosides of paeonia), and high-dose total glucosides of paeonia+zinc40099027 Zn27 group 100 μg·mL-1 total glucosides of paeonia+2 nmol·L-1 FAK activator Zn27. MTT assay was performed to measure cell proliferation. Flow cytometry was used to measure cell apoptosis. Scratch experiment was used to measure cell migration. Transwell method was performed to detect cell invasion. Western blotting Western blot was performed to detect the proteins related to the FAK/MEK/ERK signaling pathway. The human colorectal cancer drug-resistant cell line HCT116/Oxaliplatin L-OPH was constructed and divided into L-OPH-control group L-OPH-low medium and high dose total glucosides of paeonia groups and L-OPH-high dose total glucosides of paeonia+Zn27 group. The MTT assay was used to detect drug resistance in HCT116/L-OPH cells.Results: Compared with the control group the low-dose total glucosides of paeonia group medium-dose total glucosides of paeonia group and high-dose total glucosides of paeonia group showed decreased in cell survival rate scratch healing rate number of invasive cells p-FAK/FAK p-MEK1/2/MEK1/2 p-ERK1/2/ERK1/2 proteins and increased cell apoptosis rate P<0.05. Compared with the high-dose total glucosides of paeonia group the high-dose total glucosides of paeonia+Zn27 group showed increased cell survival rate scratch healing rate number of invasive cells p-FAK/FAK p-MEK1/2/MEK1/2 and p-ERK1/2/ERK1/2 proteins and decreased cell apoptosis rate P<0.05. The L-OPH-low medium and high-dose total glucosides of paeonia groups showed decreased cell survival rate than the L-OPH-control group P<0.05. The L-OPH-high-dose total glucosides of paeonia+Zn27 group had higher cell survival rate than the L-OPH-high-dose total glucosides of paeonia group P<0.05.Conclusion: total glucosides of paeonia may inhibit the proliferation migration and L-OPH resistance of colorectal cancer cells by suppressing FAK/MEK/ERK signaling pathway.

  

Cite this article

TU Jiajia, WANG Liyun, SUN Bo, WANG Fanrong .

Impacts of Total Glucosides of Paeonia on the Proliferation Migration and Oxaliplatin Resistance of Colorectal Cancer Cells by Regulating FAK/MEK/ERK Signaling Pathway

[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026 , 28(1) : 64 -64-69 . DOI: magtech.2025.05.22-00001

References

    [1 Underwood PW Ruff SM Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancerJ.Cells 2024133):245-253.

         2  Nfonsam V Wusterbarth E Gong A et al. Early-onset colorectal cancerJ.Surg Oncol Clin N Am 2022 312):143-155.

         3  Arnold MSie rra MS Laversanne M et al. Glob al patterns and trends in colorect al cancer incidence and mortalityJ. Gut 2017664):683-691.

         4  Zou Q Lei X Xu A et al. Chemokines in progressionchemoresistancediagnosisand prognosis of colorectal cancerJ.Front Immunol 2022131):724139-724152.

         5  Zhao Z Zhang G Li W. MT2A promotes oxaliplatin resistance in colorectal cancer cellsJ.Cell Biochem Biophys 2020784):475-482.

         6  杨山景,封安杰,孙越,等.白芍总苷的药理作用及机制研究进展[J.中国现代应用药学,20213813):1627-1633.

         7  Jin Y Zhang A. Total glucosides of paeony ameliorates oxidative stress apoptosis and inflammatory response by regulating the Smad7-TGF-β pathway in allergic rhinitisJ.Molecular Medicine Reports 2022253):83-92.

         8  刘慧,魏金宝,秦文静,等.白芍总苷调控舌癌HSC3细胞增殖、迁移和侵袭的机制研究[J.药物生物技术,2023302):140-146.

         9  Li QF Li ZH Luo T et al. Targeting the PI3K/Akt/mTOR and RAF/MEK/ERK pathways for cancer therapyJ.Mol Biomed 202231):47-53.

         10 Jang HJ Bak Y Pham TH et al. STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cellsJ.BMB Rep 20185111):596-601.

         11 易良波,杨菲菲,易忠禄.白芍总苷对胰腺癌细胞增殖、迁移和侵袭的作用研究[J.中医药导报,2021276):68-72.

         12 Rashmi More SK Wang Q et al. ZINC40099027 activates human focal adhesion kinase by accelerating the enzymatic activity of the FAK kinase domainJ.Pharmacol Res Perspect 202192):e00737-e00742.

         13 李莉,朱雨,姜京植,等.乙酰紫草素对耐药结肠癌细胞增殖、侵袭和迁移的影响[J.中国临床药理学杂志,20244019):2842-2846.

         14 Song M Chan AT Sun J. Influence of the gut microbiomedietand environment on risk of colorectal cancerJ.Gastroenterol 20201582):322-340.

         15 Sinicrope FA. Increasing incidence of early-onset colorectal cancerJ.N Engl J Med 202238616):1547-1558.

         16 Dariya B Aliya S Merchant N et al. Colorectal cancer biologydiagnosisand therapeutic approachesJ.Crit Rev Oncog 2020252):71-94.

         17 Jin L Guo Y Mao W et al. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signalingJ.Phytomedicine 20221041):154307-154312.

         18 孙露露,吴晓 季娟娟,等.基于PI3K/AKT信号通路探讨白芍总苷胶囊对非小细胞肺癌增殖、迁移、侵袭和凋亡的影响[J.海南医学院学报, 2025 11):1-10.

         19 Zhang ZH Xie DD Xu S et al. Total glucosides of paeony inhibits lipopolysaccharide-induced proliferationmigration and invasion in androgen insensitive prostate cancer cellsJ.PloS One 2017128):e0182584-e0182592.

         20 Riddell IA. Cisplatin and oxaliplatin our current understanding of their actionsJ.Met Ions Life Sci 2018 181):1-12.

         21 Dawson JC Serrels A Stupack DG et al. Targeting FAK in anticancer combination therapiesJ.Nat Rev Cancer 2021215):313-324.

         22 Barbosa R Acevedo LA Marmorstein R. The MEK/ERK network as a therapeutic target in human cancerJ.Mol Cancer Res 2021193):361-374.

         23 Niu X Han Q Li X et al. EDIL3 influenced the αvβ3-FAK/MEK/ERK axis of endothelial cells in psoriasisJ.J Cells in Mol Med 20222620):5202-5212.

         24 罗晓明,曾贤敏,蔡良韧,等.雷公藤红素通过FAK/MEK/ERK信号通路对肝癌细胞耐药性的影响[J.中国药房,20243520):2477-2481.

Outlines

/